Clinical application and midterm results of laparoscopic partial resection of symptomatic adenomyosis combined with uterine artery occlusion
- PMID: 19249704
- DOI: 10.1016/j.jmig.2008.12.003
Clinical application and midterm results of laparoscopic partial resection of symptomatic adenomyosis combined with uterine artery occlusion
Abstract
Study objective: To examine the clinical application of laparoscopic partial resection of symptomatic adenomyosis combined with uterine artery occlusion (UAO).
Design: Retrospective cohort study (Canadian Task Force classification III).
Setting: A district hospital.
Patients: A total of 37 patients with symptomatic adenomyosis who had indication for surgical intervention but needed conservative treatment.
Intervention: Uterine artery occlusion combined with partial resection of adenomyosis via laparoscopy.
Measurements and main results: From July 2003 through October 2005, 37 patients with symptomatic adenomyosis were treated by UAO combined with partial resection of adenomyosis via laparoscopy. All patients were followed up at 1, 6, and 12 months after the operation to estimate the volume of the uterus and changes of symptoms including pelvic pain and abnormal bleeding. Patients also were asked to participate in a clinical interview every year thereafter. No severe complications were noted during the surgical procedure or follow-up. The mean surgical time was 115.7 +/- 27.5 minutes (Mean +/- SD, 61-171 minutes), the mean blood loss was 80.0 +/- 35.2 mL (50-150 mL), and the median highest body temperature after the procedure was 38 degrees C (range 37.4 degrees C-39 degrees C). The postoperative fever morbidity was 10.8% (4/37). Improvement of menorrhagia occurred in all of 37 and 35 of 37 for dysmenorrhea. Hysterectomy was carried out in 2 patients because of persistence of dysmenorrhea. Pictorial blood loss assessment chart was used to measure menstrual blood loss and an 11-point numeric rating scale was used to evaluate the pain intensity during menstruation. The postoperative median scores of menorrhagia were 58, 56, and 59 at 1, 6, and 12 months, respectively, compared with 158 before treatment. Significant improvement occurred (p <.001, p <.001, p <.001), compared with each other, no significant difference existed (1 vs 6 months, p =.720; 6 vs 12 months, p =.992; 1 vs 12 months, p =.709). The postoperative median scores of dysmenorrhea were 7, 5, and 4 at 1, 6, and 12 months. Respectively, compared with 8 before operation; significant symptom lessening occurred (p <.001, p <.001, p <.001). Comparing with each other, significant difference also existed (1 vs 6 months, p <.001; 6 vs 12 months, p <.001; 1 vs 12 months, p =.0018). The volume of the uterus before procedure was 224.6 +/- 48.7 cm(3) (156.0-336.1 cm(3)). At 6 and 12 months it was 169.2 +/- 78.1 cm(3) (118.4-218.2 cm(3)) and 91.6 +/- 28.4 cm(3) (43.1-127.5 cm(3)), respectively. At 6 months after surgery the volume of uterus shrank 24.7% compared with preoperative volume; shrinkage rate was 59.2% at 12 months after surgery. A continuous decrease occurred (p <.001, p <.001, p <.001).
Conclusion: Laparoscopic partial resection of adenomyosis combined with UAO is an effective treatment modality for symptomatic adenomyosis, but further controlled studies with large samples and long-term follow-up is needed for a decisive conclusion.
Similar articles
-
Surgical treatment of endometriosis in private practice: cohort study with mean follow-up of 3 years.J Minim Invasive Gynecol. 2010 Jan-Feb;17(1):42-6. doi: 10.1016/j.jmig.2009.09.019. J Minim Invasive Gynecol. 2010. PMID: 20129331
-
Long-term efficacy and quality of life associated with laparoscopic bilateral uterine artery occlusion plus partial resection of symptomatic adenomyosis.Eur J Obstet Gynecol Reprod Biol. 2014 May;176:20-4. doi: 10.1016/j.ejogrb.2013.11.014. Epub 2013 Dec 17. Eur J Obstet Gynecol Reprod Biol. 2014. PMID: 24647206
-
Laparoscopic Uterine Artery Occlusion Combined with Uterine-sparing Pelvic Plexus Block and Partial Adenomyomectomy for Adenomyosis: A Video Case Report.J Minim Invasive Gynecol. 2021 Oct;28(10):1681-1684. doi: 10.1016/j.jmig.2021.05.015. Epub 2021 May 26. J Minim Invasive Gynecol. 2021. PMID: 34051355
-
Laparoscopic-assisted vaginal hysterectomy with in situ morcellation for large uteri.J Minim Invasive Gynecol. 2008 Sep-Oct;15(5):559-65. doi: 10.1016/j.jmig.2008.06.002. Epub 2008 Jul 26. J Minim Invasive Gynecol. 2008. PMID: 18657481 Review.
-
Health technology assessment of surgical therapies for benign gynaecological disease.Best Pract Res Clin Obstet Gynaecol. 2006 Dec;20(6):841-79. doi: 10.1016/j.bpobgyn.2006.11.006. Best Pract Res Clin Obstet Gynaecol. 2006. PMID: 17145485 Review.
Cited by
-
A systematic review of outcome reporting and outcome measures in studies investigating uterine-sparing treatment for adenomyosis.Hum Reprod Open. 2021 Aug 7;2021(3):hoab030. doi: 10.1093/hropen/hoab030. eCollection 2021. Hum Reprod Open. 2021. PMID: 34466664 Free PMC article. Review.
-
The Asian Society of Endometriosis and Adenomyosis guidelines for managing adenomyosis.Reprod Med Biol. 2023 Sep 10;22(1):e12535. doi: 10.1002/rmb2.12535. eCollection 2023 Jan-Dec. Reprod Med Biol. 2023. PMID: 37701076 Free PMC article.
-
Current and Prospective Treatment of Adenomyosis.J Clin Med. 2021 Jul 30;10(15):3410. doi: 10.3390/jcm10153410. J Clin Med. 2021. PMID: 34362193 Free PMC article. Review.
-
A Video Article: The Laparoscopic Uterine Artery Occlusion in Combination with Myomectomy for Uterine Myoma.Gynecol Minim Invasive Ther. 2022 May 4;11(2):114-115. doi: 10.4103/GMIT.GMIT_10_21. eCollection 2022 Apr-Jun. Gynecol Minim Invasive Ther. 2022. PMID: 35746903 Free PMC article. No abstract available.
-
Eutopic/ectopic endometrial apoptosis initiated by bilateral uterine artery occlusion: A new therapeutic mechanism for uterus-sparing surgery in adenomyosis.PLoS One. 2017 Apr 13;12(4):e0175511. doi: 10.1371/journal.pone.0175511. eCollection 2017. PLoS One. 2017. PMID: 28406930 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical